Fierce Healthcare

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media reports.

Nemours leveraged its remote clinical oversight center and its virtual nursing program to provide 24/7 oversight of qualifying pediatric patients at home.

Tampa General Hospital tapped startup Hyro to quickly roll out AI voice agents into its contact center to respond faster to patients' calls, lower its call abandonment rate and streamline appointment scheduling.

An Elation Health survey found that 76% of clinicians believe AI features are helping them provide better care, with 61% saying it is reducing stress or burnout.

The FDA is planning to tighten its regulations for vaccines, according to an internal email sent by Vinay Prasad, M.D., who heads up the agency’s Center for Biologics Evaluation and Research (CBER).

Senator Bill Cassidy, M.D., R-La., introduced the Health Information Privacy Reform Act (HIPRA) earlier this month, which would regulate wearables and consumer health apps under a HIPAA-like framework.

Cyberattack groups are changing their ransomware tactics when targeting healthcare organizations, as data extortion on the rise.

Three drugs treating chronic conditions are set for Food and Drug Administration review by the end of the year, and a new report from Optum Rx digs into why payers should be watching these decisions.

By integrating Instacart's Health Fresh Funds, more than 300,000 eligible WellTheory members can purchase clinically recommended groceries to support healthier nutrition decisions.

On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying users of its obesity and sleep apnea med Zepbound.

The U.S. has revealed price reductions for the second round of prescription drugs negotiated by Medicare through the Inflation Reduction Act. Headlining the list of 15 treatments that will undergo price reductions in 2027 are Novo Nordisk’s semaglutide products, Ozempic and Wegovy.

The Trump administration is proposing significant changes to the metrics used to calculate the Medicare Advantage star ratings.

Capital Rx has unveiled Capital Equilibrium, a new level-funding pharmacy benefit management offering.

These changes will impact how graduate nursing students access federal loans and loan forgiveness programs, nursing organizations say, and these exclusions could threaten the pipeline of graduate-level nursing professionals.

Projections from the Centers for Medicare & Medicaid Services (CMS) point to a 7.1% increase in healthcare expenditures for 2025 and an average 5.8% annual increase until 2033. That outpaces the anticipated rate of inflation and growth in gross domestic product.

A Washington state resident who was undergoing treatment for H5N5 avian influenza died on Friday, the Washington State Department of Health reported.

A study conducted by AI-enabled value-based care company Navina found that scribes produce twice as complete documentation on chronic conditions when fed more patient context.

The White House is expected to reveal a plan to address rising medical costs under the expiry of the ACA's enhanced premium tax credits, but the rollout has been delayed due to pushback from the GOP, according to media reports.

Optum Rx will reduce reauthorizations on 40 additional medications Jan. 1, surpassing initial goals set out earlier this year.

Women's health startup Millie developed an AI agent specifically to support maternal health, and, notably, the company rebuilt its data and analytics platform from the ground up with AI in mind.